• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FTC Orders Illumina to Unwind Grail Acquisition

FTC Orders Illumina to Unwind Grail Acquisition

by Glenn S. Demby | Apr 5, 2023 | News, Open Content

On Friday, the US federal trade commission ordered Illumina to divest Grail, which it acquired for $8 billion in August 2021.

Illumina Faces Proxy Battle Over Grail Acquisition

Illumina Faces Proxy Battle Over Grail Acquisition

by Glenn S. Demby | Mar 30, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

Carl Icahn has decided to take his beef with Illumina’s board of directors over the acquisition directly to company shareholders.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Lab Business: It’s Back to Basics for LabCorp & Enzo Biochem

Lab Business: It’s Back to Basics for LabCorp & Enzo Biochem

by Glenn S. Demby | Mar 20, 2023 | News, Open Content

Enzo recently announced that it is selling its lab division to LabCorp for $146 million in cash.

Amazon Makes Bold Move into DTC Healthcare Services

Amazon Makes Bold Move into DTC Healthcare Services

by Glenn S. Demby | Mar 1, 2023 | News, Open Content

Though the e-commerce giant recently closed its acquisition of One Medical, FTC antitrust intervention could disrupt Amazon’s plans.

Amazon Closes One Medical Acquisition but FTC Intervention Looms

Amazon Closes One Medical Acquisition but FTC Intervention Looms

by Glenn S. Demby | Feb 28, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

The deal closed Feb.22, but the FTC has expressed concerns about the acquisition and Amazon’s business practices in general.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com